New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the "Company" or "HSPT") (NASDAQ:HSPT) today clarified the redemption process for (i) the extraordinary general meeting for its proposed business combination (the "Business Combination") with SL BIO Ltd. ("SL Bio"), which will be held on February 12, 2026 (the "Business Combination Meeting"), and (ii) the extraordinary general meeting for its proposed amendments to HSPT's current amended and restated memorandum and articles of association, and the Investment Management Trust Agreement (collectively, the "Extension Proposals"), to extend the deadline to complete its initial business combination, which will

New York, NY, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Horizon Space Acquisition II Corp. (the "Company" or "HSPT") (NASDAQ:HSPT) today announced that it postponed the extraordinary general meeting (the "Extraordinary Meeting") originally scheduled at 9:00 a.m. Eastern Time, on February 3, 2026, to 9:00 a.m. Eastern Time, on February 12, 2026 (the "Postponement") to allow the Company additional time to engage with its shareholders. There is no change to the location, the record date, the purpose or any of the proposals to be acted upon at the Meeting. The physical location of the Meeting remains at the offices of Robinson & Cole LLP, 666 Third Avenue, 20th Floor, New York, NY 10017, and virtual

TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the "Company"), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (NASDAQ:HSPT) ("HSPT"), a publicly traded special purpose acquisition company , today announced that the registration statement on Form F-4 (the "Registration Statement"), in connection with HSPT's previously announced proposed business combination (the "Business Combination") with SL Bio, has been declared effective by the U.S. Securities and Exchange Commission (the "SEC") on January 13, 2026. The declaration of effectiveness by the SEC and the filing of the def

425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)

DEFA14A - Horizon Space Acquisition II Corp. (0002032950) (Filer)

425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)

8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)

425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)

DEFA14A - Horizon Space Acquisition II Corp. (0002032950) (Filer)

425 - Horizon Space Acquisition II Corp. (0002032950) (Subject)

8-K - Horizon Space Acquisition II Corp. (0002032950) (Filer)

DEF 14A - Horizon Space Acquisition II Corp. (0002032950) (Filer)

DEFA14A - Horizon Space Acquisition II Corp. (0002032950) (Filer)